Fundraising Fox480 Biomedical
Watertown, US · Delaware corporation · 4 known investors
Find your way into 480 Biomedical
Sign up to find every way you can get introduced to 480 Biomedical
- Your email: who you already know at 480 Biomedical, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the 480 Biomedical team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Founders & leadership
MP
Maria PalasisExecutive
Board
RL
GN
Guido NeelsBoard director
TM
RM
Richard MottBoard director
CS
TS
Tony SemedoBoard director
DD
Dennis DoughertyBoard directorManaging General Partner at Intersouth Partners
GW
George WhitesidesBoard director
Investors · 4
Broadview VenturesreportedBoston
How we know: a partner's Signal profile · funding news · Not right? Tell us
Essex Woodlands Healthcare PartnersinferredNew York · $20M – $80M
How we know: board seat on SEC Form D · Not right? Tell us
North Bridge Venture Partners & Growth EquityreportedWellesley
How we know: funding news · press coverage · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$184.5M disclosed across 4 rounds · 2016–2023
▶$50MraisedJun 2023 · 24 investors · BiotechnologyRule 506(b)
▶$50MraisedJun 2023 · 24 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- W. Bradford SmithDirector
- Konstantin PoukalovDirector
- Maria Palasis, Ph.D.Executive Officer, Director
- James R. TobinDirector
- Nancy Snyderman, M.D., FACSDirector
- C. Ann MerrifieldDirector
- Richard Nieman, M.D.Executive Officer
- Harlan Waksal, M.D.Executive Officer, Director
- John Bishop, Ph.D.Executive Officer
- Jason CavalierExecutive Officer
- Michael AltmanDirector
- Edward AndersonDirector
- Offering amount
- $50M
- Amount sold
- $50M
- Sales commissions
- $3.1M
- Placement agents
- William Blair & Company, L.L.C., Cantor Fitzgerald & Co., H.C. Wainwright & Co., LLC
- First sale
- May 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$100.5MraisedApr 2022 · 34 investors · BiotechnologyRule 506(b)
▶$100.5MraisedApr 2022 · 34 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Harlan Waksal, M.D.Executive Officer, Director
- Jason CavalierExecutive Officer
- Maria Palasis, Ph.D.Executive Officer, Director
- Michael AltmanDirector
- Nancy Snyderman, M.D., FACSDirector
- Konstantin PoukalovDirector
- Robert Richard, Ph.D.Executive Officer
- Pamela NelsonExecutive Officer
- Edward AndersonDirector
- C. Ann MerrifieldDirector
- W. Bradford SmithDirector
- Corinne NoyesExecutive Officer
- James R. TobinDirector
- Offering amount
- $100.5M
- Amount sold
- $100.5M
- Sales commissions
- $3.8M
- Placement agents
- MTS Securities, LLC
- First sale
- Apr 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$28MraisedJan 2020 · 14 investors · OtherRule 506(b)
▶$28MraisedJan 2020 · 14 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Konstantin PoukalovDirector
- Ann MerrifieldDirector
- Bradford SmithDirector
- George WhitesidesDirector
- Maria Palasis, Ph.D.Executive Officer, Director
- Robert LangerDirector
- Edward AndersonDirector
- Don ElseyExecutive Officer
- Michael AltmanDirector
- Offering amount
- $28M
- Amount sold
- $28M
- First sale
- Jan 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$6MraisedNov 2016 · 9 investors · OtherRule 506(b)
▶$6MraisedNov 2016 · 9 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Robert LangerDirector
- Guido NeelsDirector
- Maria PalasisDirector, Executive Officer
- Terrance McGuireDirector
- Richard MottDirector
- Carmichael S. RobertsDirector
- Tony SemedoDirector
- George WhitesidesDirector
- Dennis DoughertyDirector
- Offering amount
- $6M
- Amount sold
- $6M
- First sale
- Nov 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through 480 Biomedical went on to found or lead other companies.
Frequently asked questions
- Who are 480 Biomedical's investors?
- 480 Biomedical's investors include Broadview Ventures, Essex Woodlands Healthcare Partners, North Bridge Venture Partners & Growth Equity, Polaris Partners.
- How much funding has 480 Biomedical raised?
- 480 Biomedical has disclosed $184.5M raised across 4 rounds.
- Where is 480 Biomedical headquartered?
- 480 Biomedical is headquartered in Watertown, US.